Prasad Parmeshwaran Joins Lazard as a Managing Director in Healthcare Group, Financial Advisory

Rhea-AI Summary

Lazard Ltd (NYSE: LAZ) has appointed Prasad Parmeshwaran as a Managing Director in its Healthcare Group within Financial Advisory, effective immediately. Based in San Francisco, Mr. Parmeshwaran will primarily focus on advising clients in the biotechnology and diagnostics sectors. He brings nearly two decades of relevant experience, most recently as Managing Director at Cowen Inc. where he led the Healthcare M&A group. His expertise is expected to strengthen Lazard’s capabilities in advising on strategic transactions in the healthcare space.

Positive

• Hiring of experienced Managing Director Prasad Parmeshwaran strengthens Lazard's Healthcare Group.
• Parmeshwaran brings nearly two decades of experience in healthcare financial advisory.
• Expansion of Lazard's presence in biotechnology and diagnostics sectors.

Negative

• None.

NEW YORK--(BUSINESS WIRE)-- Lazard Ltd (NYSE: LAZ) announced today that Prasad Parmeshwaran has joined the firm as a Managing Director in the Healthcare Group within Financial Advisory, effective immediately. Based in San Francisco, Mr. Parmeshwaran primarily advises clients on financial matters in the biotechnology and diagnostics sectors.

“We welcome Prasad, who brings nearly two decades of advising healthcare clients, particularly in biotechnology and diagnostics M&A,” said David Gluckman, Global Head of the Healthcare Group at Lazard. “He joins our well-established team on the West Coast, bolstering our presence advising on private and public strategic transactions.”

Prior to joining Lazard, Mr. Parmeshwaran was a Managing Director at Cowen Inc. where he built and oversaw the firm’s Healthcare M&A group since 2016. Earlier in his career he held investment banking roles in the healthcare group at Goldman Sachs, where he worked for 10 years. Mr. Parmeshwaran obtained his postgraduate diploma in management from the Indian Institute of Management, and his M.B.A. from the New York University Stern School of Business.

About Lazard

Lazard, one of the world's preeminent financial advisory and asset management firms, operates from 40 cities across 25 countries in North and South America, Europe, Asia and Australia. With origins dating to 1848, the firm provides advice on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments and individuals. For more information on Lazard, please visit www.lazard.com. Follow Lazard at @Lazard

LAZ-FAPE

View source version on businesswire.com: https://www.businesswire.com/news/home/20220720005283/en/

Media:

Judi Frost Mackey, +1 212 632 1428

judi.mackey@lazard.com

Investors:

Alexandra Deignan, +1 212 632 6886

alexandra.deignan@lazard.com

Source: Lazard Ltd

FAQ

Who is Prasad Parmeshwaran and what is his role at Lazard?

Prasad Parmeshwaran has joined Lazard as a Managing Director in the Healthcare Group, focusing on financial advisory in biotechnology and diagnostics.

What is the significance of Parmeshwaran's appointment at Lazard?

Parmeshwaran's appointment is significant as it enhances Lazard's expertise and presence in the healthcare advisory sector.

What experience does Prasad Parmeshwaran bring to Lazard?

He brings nearly two decades of experience in healthcare financial advisory, including leadership roles at Cowen Inc. and Goldman Sachs.

When did Prasad Parmeshwaran start his role at Lazard?

Prasad Parmeshwaran's role at Lazard began immediately upon his appointment, announced today.

How will Parmeshwaran's role impact Lazard's Healthcare Group?

His expertise is expected to bolster Lazard's ability to advise on private and public strategic transactions in healthcare.